Progressive Supranuclear Palsy Clinical Trials This is an RSS file. You can use it to subscribe to this data in your favourite RSS reader or to display this data on your own website or blog.

Chromatic Pupillometry to Assess the Melanopsin-Light Pathway in Progressive Supranuclear Palsy
Conditions: PSP - Progressive Supranuclear Palsy; PD - Parkinson's Disease; AD - Alzheimer's Disease; ALS (Amyotrophic Lateral Sclerosis) Intervention: Diagnostic Test: Pupillometry Sponsors: Massachusetts General Hospital; NeurOptics Inc.; University of Toronto Recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 2, 2017 Category: Research Source Type: clinical trials

Chromatic Pupillometry to Assess the Melanopsin-Light Pathway in Progressive Supranuclear Palsy
Conditions: PSP - Progressive Supranuclear Palsy; PD - Parkinson's Disease; AD - Alzheimer's Disease; ALS (Amyotrophic Lateral Sclerosis) Intervention: Diagnostic Test: Pupillometry Sponsors: Massachusetts General Hospital; NeurOptics Inc.; University of Toronto Not yet recruiting (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - November 2, 2017 Category: Research Source Type: clinical trials

Study of BMS-986168 in Patients With Progressive Supranuclear Palsy
Condition: Progressive Supranuclear Palsy Interventions: Biological: BMS-986168; Biological: Placebo Sponsor: Bristol-Myers Squibb Not yet recruiting - verified February 2017 (Source: ClinicalTrials.gov)
Source: ClinicalTrials.gov - February 27, 2017 Category: Research Source Type: clinical trials